Rethinking Risk in Clinical Research

David Rubinow, Introduction and Welcome:
Rethinking Risk in Clinical Research

Jane Pearson, Acting Deputy Director,Division of Services and Intervention Rsearch, NIMH, NIH:
Including High Risk Patients in NIMH RCTs

Lydia Lewis, President, The Depression and Bipolar Support Alliance:
Patient Advocates; Nothing For Us Without Us

James Harris, Director, Developmental Neuropsychiatry, Johns Hopkins University School of Medicine:
Rethinking Risk in Clinical Research 

Paul Andreason, Acting Deputy Director, Division of Psychiatric Products, FDA:
Managing Risk During Drug Development

Questions and Answers